Chinese herbal medicine (“3 medicines and 3 formulations”) for COVID ‐19: rapid systematic review and meta‐analysis

Author:

Wang Yangzihan1ORCID,Greenhalgh Trisha2ORCID,Wardle Jon3ORCID,

Affiliation:

1. Population Health Science Institute Newcastle University Newcastle upon Tyne UK

2. The Nuffield Department of Primary Care Health Sciences University of Oxford Oxford UK

3. National Centre for Naturopathic Medicine Southern Cross University Lismore New South Wales Australia

Funder

NIHR School for Primary Care Research

Wellcome Trust

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference51 articles.

1. China NHCotPsRo. The diagnosis and treatment plan for pneumonia caused by novel Coronavirus Beijing China ADD.2020.

2. BaiJ.The epidemic can only be relieved after 90% of Hong Kong population get infected. Experts: impossible. China News.2020.

3. Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19

4. Herbal medicine for the management of COVID‐19 during the medical observation period: a review of guidelines;Ang L;Integr Med Res,2020

5. Natural herbal medicine Lianhuaqingwen capsule anti‐influenza a (H1N1) trial: a randomized, double blind, positive controlled clinical trial;Duan ZP;Chin Med J (Engl),2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3